Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

Validation of a Comprehensive Genomic Profiling Assay: NeXT Dx™

News

August 30, 2023
PRESS RELEASE: On August 30, 2023, a new research paper was published in Oncotarget, entitled, “Analytic validation of NeXT Dx™, a comprehensive genomic profiling assay.” continue reading »

Adopted Neoplastic Cells and the Consequences of Their Existence

News

August 29, 2023
PRESS RELEASE: On April 14, 2023, a new research perspective was published in Oncotarget, entitled, “Adopted neoplastic cells and the consequences of their existence.” continue reading »

Behind the Study: ER Expression Multiclonality in DCIS: Clinical & Future Insights

Oncotarget

August 29, 2023
Dr. Mangesh A. Thorat describes a recent editorial he authored that was published by Oncotarget in Volume 14, entitled, “Multiclonality of ER expression in DCIS – Implications for clinical practice and future research.” continue reading »

A Macrophage is a Macrophage is a Macrophage—in Metastasis

News

August 23, 2023
PRESS RELEASE: On June 6, 2023, a new editorial was published in Oncotarget, entitled, “A macrophage is a macrophage is a macrophage—in metastasis.” continue reading »

Aggressive Luminal Breast Cancer: Are Cis-Spliced Fusion Proteins Pathological?

News

August 21, 2023
PRESS RELEASE: On June 12, 2023, a new editorial paper was published in Oncotarget, entitled, “Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?” continue reading »